PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
30-Oct-2019 Danaher Announces Pricing Of Senior Notes Offering Danaher Corporation
29-Oct-2019 MorphoSys AG Reports Third Quarter 2019 Financial Results (news with additional features) MorphoSys AG
29-Oct-2019 MorphoSys AG: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone (news with additional features) MorphoSys AG
29-Oct-2019 MorphoSys AG: Ad hoc: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone MorphoSys AG
29-Oct-2019 PharmiWeb To Launch In Australia PharmiWeb.Jobs
29-Oct-2019 Upperton continues to invest in key equipment to support expansion of its solid dosage form capabilities and CDMO services Upperton Pharma Solutions
29-Oct-2019 European CNS specialist Neuraxpharm enters booming CBD market Neuraxpharm Group
29-Oct-2019 Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019 (news with additional features) Expedeon AG
29-Oct-2019 Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019 Expedeon AG
29-Oct-2019 Exclusive interview from conference speaker Richard Marsden released ahead of SMi’s Respiratory Drug Delivery Conference SMi Group
29-Oct-2019 In The Longest-Running Post-Marketing Surveillance Study Of Its Type, Data At 24 Months On FDgard®, Presented At The American College Of Gastroenterology (ACG) Annual Meeting, Confirms Excellent Safety And Tolerability Profile Of This Nonprescription Product For Functional Dyspepsia (Meal-Triggered, Recurring Indigestion[i]) IM HealthScience
29-Oct-2019 Phio Pharmaceuticals to Highlight Self-delivering RNAi Technology at SITC 2019 Phio Pharmaceuticals Corp.
29-Oct-2019 Gordian Surgical Raises $3 Million for Commercialization of Its Laparoscopic Closure System Gordian Surgical
29-Oct-2019 Blueprint Medicines to Host R&D Day and Announce Third Quarter 2019 Financial Results on November 5, 2019 Blueprint Medicines
29-Oct-2019 Curis to Release Third Quarter Financial Results and Hold Conference Call on November 5, 2019 Curis, Inc.
29-Oct-2019 XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa XBiotech
29-Oct-2019 Tillotts partners Menarini to extend Asacol® to the People’s Republic of China Tillotts Pharma AG
29-Oct-2019 Oracle Health Sciences and Phlexglobal Collaborate to Reduce Operational Bottlenecks in Clinical Research Phlexglobal
29-Oct-2019 MPH Health Care AG: Preliminary IFRS result for third quarter of 2019: NAV per share at EUR 5.60 still well above current stock level MPH Health Care AG
29-Oct-2019 BioVersys Receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies B3C newswire